Through their patented technology, TRACTIVUS creates nanostructures on the surface of medical devices to prevent bacteria attachment and colonization, resulting in longer device lifetimes, reduced costs, and improved patient outcomes. Their focus is on developing personalized medical devices with bioactive properties, such as trachea prostheses, that enhance adaptability and interaction with surrounding tissues. By revolutionizing implantable devices and treatments, TRACTIVUS aims to improve patients' quality of life, minimize post-implantation complications, and provide targeted drug delivery solutions.